Traditional cancer therapies aim to destroy tumor cells, often damaging nearby healthy tissue and triggering harsh side effects. Publishing their results in Advanced Science, the
India’s pharmaceutical sector is experiencing significant relief as the prices of Active Pharmaceutical Ingredients (APIs) have dropped sharply, thanks to increased domestic production and aggressive
New York: AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a new study that is likely
Researchers at the Indian Institute of Science (IISc.) have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood
Kiran Mazumdar-Shaw’s booming drug business started not in a laboratory but in a tin-roofed shed in Bengaluru, the city formerly known as Bangalore and the
Indian healthcare sector is poised for a significant transformation, driven by the integration of advanced technologies. Artificial intelligence (AI) is becoming a core component of
In a significant move aimed at strengthening cross-border industrial collaboration, India’s pharmaceutical companies have been invited to explore lucrative partnerships with Saudi Arabia, as the
Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice® Air in its respiratory inhalers at scale, redefining respiratory care with near-zero
The State of Kerala, which is very backward in pharmaceutical production, is now poised to become a hub of medical devices manufacturing and ancillary companies